QIAGEN powered by

Webinars and events

Loading Events

« All Events

  • This event has passed.

Accéder rapidement à une connaissance exhaustive pour l’interprétation des variants somatiques avec HSMD

March 30, 2023 @ 10:00 am - 11:00 am

L’interprétation et la classification des variants somatiques demeurent un challenge alors que le nombre de gènes testés continue d’augmenter faisant apparaitre de nouvelles altérations. Ces nouveaux variants dont l’impact clinique est encore inconnu nécessitent une recherche d’information croisée à partir de nombreuses sources. Déterminer la classification d’un variant peut donc s’avérer longue et fastidieuse. La base de variants somatiques HSMD est une ressource en ligne qui vous permet rapidement et en toute confiance de classer vos nouveaux variants. En effet, HSMD contient plus de 300 000 cas en oncologie clinique et plus de 1,5 millions de mutations et leurs données associées, manuellement capturées et intégrées dans la base de connaissance QIAGEN. Le profil mutationnel de gènes d’intérêt, les gènes fréquemment mutés dans une pathologie donnée, l’actionnabilité d’un gène ou encore les essais cliniques pour un cancer ou un traitement spécifique sont des requêtes que les utilisateurs d’HSMD peuvent effectuer simplement. Vous découvrirez lors de ce webinaire comment utiliser HSMD pour votre routine clinique ou dans un cadre de recherche translationnelle.


Date: March 30, 2023
 10:00 am - 11:00 am
Register for event
Event Categories:


Clinical, Training
Register for event

On-demand Webinars

  • On-demand webinar: Get insights into the bioinformatics analysis of Nanopore sequencing data for SARS-CoV-2

    The study of the COVID-19 pandemic often involves sequencing the SARS-CoV-2 virus using Illumina, Nanopore, IonTorrent and Sanger technologies alone or in combination. Depending on the sampling and library preparation method used, this can involve metatranscriptomic data of varying viral content. In this webinar tutorial, you will learn about: Best practices for ...

  • On-demand webinar: Discover hidden relationships in your toxicological studies with QIAGEN IPA

    QIAGEN Ingenuity Pathway Analysis (IPA) reveals the hidden upstream drivers and downstream outcomes in your toxicogenomics datasets. Put those results into context using Analysis Match with over 50,000 pre-analyzed datasets for human, mouse and rat. Explain the causes and effects in your studies so you can generate hypotheses to develop better drugs, biomarkers and mo...

  • On-demand web seminar: Enabling high-throughput genomic surveillance of emerging SARS-CoV-2 strains

    Join our webinar to discover a scalable workflow for SARS-CoV-2 whole genome sequencing to accelerate detection of variants such as B.1.1.7 and B.1.351. In this new webinar, we will describe how QIAGEN’s QIAseq SARS-CoV-2 integrated workflow combines QIAseq chemistries and CLC Genomics Analysis software to deliver a scalable, high-performance solution for sequencing...

  • On-demand webinar: Investigation of Somatic and Germline Variants by COSMIC, HGMD and QIAGEN Databases

    Identifying and studying actionable variants is of great interest to many investigators. In this webinar, COSMIC, HGMD and QIAGEN database will be introduced for annotation and investigation of both somatic and germline variants. Attendees will learn how to use QIAGEN Clinical Insight Interpret Translational (QCI-IT) to identify key actionable variants from whole geno...

  • On-demand Webinar: Whole exome sequencing (WES) helps understand exceptional survival in rare sarcoma patient

    In this webinar presented by Rockefeller University, Danbury Hospital and QDI, we present a unique case study of a treatment-naïve patient with aggressive metastatic uLMS who has experienced long-term survival. Using whole exome sequencing (WES), we analyzed 5 tumors to identify mechanisms of uLMS tumor growth and metastasis in this patient. Attendees of this webi...

  • On-demand Webinar: Accelerate R&D in new cancer drug development

    Learn about a new database that helps you accelerate cancer drug development. This is the ONE tool that all translational research programs need to accelerate cancer drug R&D. Free trials offered to all attendees.   Webinar Abstract The paradigm of predictive biomarkers of therapeutic responses to drug intervention has dramatically transformed cancer...

  • On-demand Webinar: Comprehensive Molecular Tumor Analysis with Alacris Theranostics

    Join Dr. Marie-Laure Yaspo, Co-Founder and Chief Scientific Officer of Alacris Theranostics, as she discusses the development, application, and analysis of the Comprehensive Molecular Tumor Analysis (CMTA) test for cancer patients. Precision oncology approaches have made great strides harnessing individual tumor mutation profiles to guide targeted therapy choic...